AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 17016527
Drug: Standardized IOP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standardized IOP treatment protocol
Trial: 9062507
Drug: Regular insulin
RxNorm normalized name: Regular insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular insulin (0.15 U/kg)
Trial: 9062507
Drug: Lispro insulin
RxNorm normalized name: Lispro insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lispro insulin (0.15 U/kg)
Trial: 9062507
Drug: Lispro insulin
RxNorm normalized name: Lispro insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lispro insulin (0.1 U/kg)
Trial: 9062507
Drug: Ultralente insulin
RxNorm normalized name: ultralente insulin, beef
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultralente insulin (0.2 U/kg)
Trial: 1288510
Drug: Trospium chloride
RxNorm normalized name: Trospium Chloride
DrugBank: Trospium (DB00209)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Trospium chloride 0.2 mg i.v.
Trial: 1288510
Drug: Trospium chloride
RxNorm normalized name: Trospium Chloride
DrugBank: Trospium (DB00209)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Trospium chloride 0.5 mg i.v.
Trial: 1288510
Drug: Trospium chloride
RxNorm normalized name: Trospium Chloride
DrugBank: Trospium (DB00209)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Trospium chloride 1.0 mg i.v.
Trial: 1288510
Drug: Trospium chloride
RxNorm normalized name: Trospium Chloride
DrugBank: Trospium (DB00209)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Trospium chloride 1.5 mg i.v.
Trial: 1288510
Drug: n-butylscopolamine bromide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: n-butylscopolamine bromide 20 mg i.v.
Trial: 30739935
Drug: Bupivacaine 2
RxNorm normalized name: bupivacaine 29.3 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 2 mg/kg
Trial: 30739935
Drug: Bupivacaine 2
RxNorm normalized name: bupivacaine 29.3 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 2 mg/kg with Clonidine 1 µg/kg
Trial: 29435955
Drug: Neuromuscular manual
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neuromuscular manual therapy
Trial: 29435955
Drug: Back massage
RxNorm normalized name: Pep-Back
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Back massage therapy
Trial: 17713400
Drug: Tight glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tight glucose control by intensive insulin therapy
Trial: 31563122
Drug: 6% carbohydrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6% carbohydrate solution
Trial: 10470753
Drug: Liposomal prostaglandin
RxNorm normalized name: Liposomal prostaglandin E1
DrugBank: Liposomal prostaglandin E1 (DB05391)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liposomal prostaglandin E1 (with at least 85% of full dose)
Trial: 287554
Drug: Adjuvant high-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant high-dose methotrexate and aggressive resection of pulmonary metastases
Trial: 30907987
Drug: Levothyroxine 50
RxNorm normalized name: LEVOTHYROXINE 50MCG/ML ORAL SOLN UD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levothyroxine 50 μg once daily
Trial: 23529786
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg oral tablet of bilastine
Trial: 23529786
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg intravenous formulation of bilastine
Trial: 14657226
Drug: Chemotherapy alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy alone (CTh)
Trial: 11136909
Drug: 3000 U
RxNorm normalized name: lipase 3000 UNT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3000 U anti-factor Xa certoparin once daily
Trial: 11136909
Drug: 3000 U
RxNorm normalized name: lipase 3000 UNT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3000 U anti-factor Xa certoparin twice daily
Trial: 11136909
Drug: 5000 U
RxNorm normalized name: lipase 5000 UNT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5000 U anti-factor Xa certoparin twice daily
Trial: 11136909
Drug: 8000 U
RxNorm normalized name: lipase 8000 UNT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8000 U anti-factor Xa certoparin twice daily
Trial: 11136909
Drug: Treatment group
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment group 4
Trial: 11136909
Drug: During certoparin
RxNorm normalized name: certoparin
DrugBank: Certoparin (DB09261)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: During certoparin treatment
Trial: 3312399
Drug: Thiothixene (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiothixene (60 mg daily)
Trial: 21741309
Drug: Dignity therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dignity therapy
Trial: 24728212
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg aspirin plus 2 g calcium daily until delivery
Trial: 20173085
Drug: Raltegravir 400
RxNorm normalized name: raltegravir 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Raltegravir 400 mg every 12 hours for 10 days
Trial: 17658393
Drug: Aliskiren 300
RxNorm normalized name: aliskiren 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aliskiren 300 mg and Valsartan 320 mg
Trial: 7589032
Drug: 0.075 mg
RxNorm normalized name: mestranol 0.075 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.075 mg gestodene and 0.03 mg ethinylestradiol
Trial: 7589032
Drug: 0.125 mg
RxNorm normalized name: digoxin 0.125 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.125 mg levonorgestrel and 0.03 mg ethinylestradiol
Trial: 7589032
Drug: Both contraceptive
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both contraceptive formulations
Trial: 7589032
Drug: Post-treatment (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Post-treatment (1 month after last intake)
Trial: 2107743
Drug: Hydralazine 50
RxNorm normalized name: hydralazine 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydralazine 50 mg bid
Trial: 2107743
Drug: Hydralazine 100
RxNorm normalized name: hydralazine 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydralazine 100 mg bid
Trial: 2107743
Drug: Indomethacin 50
RxNorm normalized name: indomethacin 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin 50 mg bid
Trial: 293505
Drug: Randomized suppressive
RxNorm normalized name: jojoba oil, randomized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Randomized suppressive therapy trial
Trial: 22511916
Drug: Daily oral
RxNorm normalized name: GEMTESA 75 MG Once-Daily Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily oral FTC/TDF
Trial: 29255900
Drug: Galcanezumab 300
RxNorm normalized name: Galcanezumab
DrugBank: Galcanezumab (DB14042)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Galcanezumab 300 mg
Trial: 26547351
Drug: Bicyclol combined
RxNorm normalized name: Bicyclol
DrugBank: Bicyclol (DB16014)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bicyclol combined with ganciclovir (bicyclol 3 mg/kg, twice daily; ganciclovir 5 mg/kg)
Trial: 26547351
Drug: Ganciclovir alone
RxNorm normalized name: Ganciclovir
DrugBank: Ganciclovir (DB01004)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ganciclovir alone (5 mg/kg)
Trial: 25618967
Drug: Chishaodanpi decoction
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chishaodanpi decoction (CSDPD), 100 mL twice a day for 8 weeks, in addition to control treatment.
Trial: 25618967
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group treatment with potassium magnesium aspartate, diammonium glycyrrhizinate, glucurolactone, vitamin C, and lamivudine, once a day for 8 weeks.
Trial: 25618967
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups received treatment for 8 weeks.
Trial: 22176384
Drug: Probiotics (exact
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotics (exact dosage and duration not specified)
Trial: 19998861
Drug: Daily journal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily journal
Trial: 14748891
Drug: Levothyroxine (L‐T4)
RxNorm normalized name: L-T4
DrugBank: Levothyroxine (DB00451)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Levothyroxine (L‐T4) treatment for 1 year
Trial: 11302598
Drug: Morphine-infused silver
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine-infused silver sulfadiazine cream
Trial: 9631981
Drug: Maximally tolerated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maximally tolerated oral therapy (diuretics, vasodilators, and digitalis)
Trial: 9631981
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy at standard doses
Trial: 5312248
Drug: Amantadine hydrochloride
RxNorm normalized name: Amantadine Hydrochloride
DrugBank: Amantadine (DB00915)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amantadine hydrochloride (100 mg daily)
Trial: 28423969
Drug: PULSE Program
RxNorm normalized name: PUMP,LUTREPULSE PROGRAMMABLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PULSE Program intervention (self-administered lifestyle intervention focused on weight loss, diet, and exercise)
Trial: 26697487
Drug: Pharmaceutical Intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pharmaceutical Intervention (PI) - information booklets, 30 min face-to-face medication education and psychological counseling by clinical pharmacists, 2 sessions per week for 2 months
Trial: 26697487
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group - conventional treatment only
Trial: 21696849
Drug: Nutrilarm(®) capsules
RxNorm normalized name: NuTriaRX CreamPak KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutrilarm(®) capsules (omega-3 and omega-6), twice a day for 6 months
Trial: 21696849
Drug: Nutrilarm(®) capsules
RxNorm normalized name: NuTriaRX CreamPak KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutrilarm(®) capsules
Trial: 16254268
Drug: Intravenous salbutamol
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous salbutamol (15 microg kg(‐1) h(‐1)) for 7 days
Trial: 12968981
Drug: Liposomal daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liposomal daunorubicin (Daunoxome) administered as a 1‐ to 2.5 h infusion with doses ranging from 30 to 60 mg m(‐2)
Trial: 8941095
Drug: High dietary
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dietary fiber intake (median, 34.8 g/d)
Trial: 8941095
Drug: Low dietary
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dietary fiber intake (median, 16.1 g/d)
Trial: 1417428
Drug: Active imipramine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active imipramine hydrochloride treatment maintained at an average dose of 200 mg
Trial: 6433715
Drug: Sensory stimulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sensory stimulation therapy
Trial: 29725702
Drug: Menthol Vuse
RxNorm normalized name: Menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Menthol Vuse Solo electronic cigarettes (14, 29, and 36 mg nicotine)
Trial: 22399124
Drug: 50 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg/kg i.v. Magnesium
Trial: 12355576
Drug: 5-aminolevulinic acid
RxNorm normalized name: 5-aminolevulinic acid
DrugBank: Aminolevulinic acid (DB00855)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 5-aminolevulinic acid (ALA) as a topically applied photosensitizer for photodynamic therapy (PDT) with a fixed dose of ALA (200 mg/ml) and escalating radiant energies (50-150 J/cm(2)).
Trial: 1568519
Drug: Sulodexide (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulodexide (500 lipoproteinlipase releasing units twice daily for 1 month)
Trial: 3917968
Drug: Parenteral amino
RxNorm normalized name: parenteral amino acid 7 % comb no.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral amino acid-glucose solution for 1 month
Trial: 3917968
Drug: Glucose solution
RxNorm normalized name: TrueControl Glucose Solution Level 0
DrugBank: Dextrose, unspecified form (DB09341)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glucose solution without amino acids
Trial: 3917968
Drug: Parenteral amino
RxNorm normalized name: parenteral amino acid 7 % comb no.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral amino acid-glucose solution
Trial: 12620945
Drug: General Anesthesia
RxNorm normalized name: Ethers for general anesthesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: General Anesthesia (GA) with propofol 2.5 mg x kg(‐1) and fentanyl 1 micro g x kg(‐1) maintained with N(2)O‐O(2) 50:50 and desflurane for 30 min
Trial: 27222733
Drug: Dose counter
RxNorm normalized name: Qvar with Dose Counter
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dose counter adherence
Trial: 21125461
Drug: Clazosentan 5
RxNorm normalized name: clazosentan
DrugBank: Clazosentan (DB06677)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Clazosentan 5 mg/h
Trial: 21125461
Drug: Clazosentan 15
RxNorm normalized name: clazosentan
DrugBank: Clazosentan (DB06677)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Clazosentan 15 mg/h
Trial: 17696126
Drug: Natalizumab 300
RxNorm normalized name: natalizumab 300 MG in 15 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Natalizumab 300 mg (n = 627)
Trial: 17696126
Drug: Interferon beta‐1a
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon beta‐1a plus natalizumab 300 mg (n = 589)
Trial: 15877671
Drug: Subcutaneous darbepoetin
RxNorm normalized name: Darbepoetin Alfa
DrugBank: Darbepoetin alfa (DB00012)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Subcutaneous darbepoetin
Trial: 15877671
Drug: Intravenous darbepoetin
RxNorm normalized name: Darbepoetin Alfa
DrugBank: Darbepoetin alfa (DB00012)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous darbepoetin
Trial: 9796239
Drug: Unilateral spinal
RxNorm normalized name: Bos taurus spinal cord preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unilateral spinal anaesthesia with 8 mg of 0.5% hyperbaric bupivacaine
Trial: 9796239
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group with bilateral spinal anaesthesia using 15 mg of 0.5% hyperbaric bupivacaine
Trial: 7638814
Drug: Inhaled frusemide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled frusemide (20 mg)
Trial: 2533763
Drug: Diltiazem (90
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem (90 mg three doses by mouth)
Trial: 2533763
Drug: Isradipine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isradipine (5 mg three doses by mouth)
Trial: 25126421
Drug: 6MHP vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6MHP vaccine
Trial: 10701035
Drug: 1% lignocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% lignocaine 1.6 ml and 4 mg morphine
Trial: 10701035
Drug: 1% lignocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% lignocaine 2 ml
Trial: 21574837
Drug: GapSeal gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GapSeal gel
Trial: 22374870
Drug: No prednisolone
RxNorm normalized name: Prednisolone
DrugBank: Prednisolone acetate (DB15566)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No prednisolone treatment (Control)
Trial: 2354694
Drug: gari as
FDA approved: no
EMA approved: no
PMDA approved: no
Description: gari as eba 50 g
Trial: 2354694
Drug: lafun 50
RxNorm normalized name: minoxidil
DrugBank: Minoxidil (DB00350)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: lafun 50 g
Trial: 2354694
Drug: parboiled cassava
RxNorm normalized name: cassava
FDA approved: no
EMA approved: no
PMDA approved: no
Description: parboiled cassava flakes 76 g
Trial: 26665746
Drug: Art Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Art Therapy (AT) in addition to Psychotherapy (PT)
Trial: 23980737
Drug: CET (Concurrent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CET (Concurrent Exercise Training)
Trial: 19109574
Drug: Azathioprine (2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azathioprine (2.0 mg/kg/day)
Trial: 19109574
Drug: Methotrexate (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methotrexate (0.3 mg/kg/week, increased to 25 mg/week)
Trial: 17146324
Drug: 4.5 mg.kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4.5 mg.kg caffeine
Trial: 17146324
Drug: 9.0 mg.kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 9.0 mg.kg caffeine
Trial: 12710402
Drug: VaxGen vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VaxGen vaccine
Trial: 10671332
Drug: Itraconazole (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Itraconazole (100 mg orally twice daily)
Trial: 3964534
Drug: Neat oil
RxNorm normalized name: neatsfoot oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neat oil suspension (Sandimmun)
Trial: 29936921
Drug: Liquid ubiquinol
RxNorm normalized name: ubiquinol Oral Liquid Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liquid ubiquinol (100 mg/d)
Trial: 20393402
Drug: 35 mg
RxNorm normalized name: papain 35 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 35 mg risedronate weekly, vitamin D, and calcium
Trial: 15917045
Drug: Healthy Eating
RxNorm normalized name: Healthy Mama
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Healthy Eating and Lifestyle Program (10 weekly weight loss classes)
Trial: 12526935
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg/day for 14 days
Trial: 12526935
Drug: Pantoprazole 40
RxNorm normalized name: pantoprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pantoprazole 40 mg/day for 14 days
Trial: 3190996
Drug: Soluble aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soluble aspirin 600 mg
Trial: 3190996
Drug: Soluble aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soluble aspirin 1200 mg
Trial: 3190996
Drug: Aspirin tablet
RxNorm normalized name: Aspirin Tablets
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin tablet 1200 mg
Trial: 3190996
Drug: Aspirin tablets
RxNorm normalized name: Aspirin Tablets
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin tablets 600 mg
Trial: 3190996
Drug: Aspirin tablets
RxNorm normalized name: Aspirin Tablets
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin tablets 900 mg
Trial: 31891553
Drug: Interportal capsulotomy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interportal capsulotomy with closure (CC)
Trial: 26552099
Drug: AllergiSense smartphone
RxNorm normalized name: catfish allergenic extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AllergiSense smartphone app and sensing system for injection training and feedback
Trial: 25409596
Drug: Pexacerfont (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pexacerfont (300 mg/day for 7 days, followed by 100 mg/day for 23 days)
Trial: 25409596
Drug: Open-label pexacerfont
RxNorm normalized name: strontium chloride, 89Sr-labeled
DrugBank: Strontium chloride Sr-89 (DB09498)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Open-label pexacerfont (same dosing regimen)
Trial: 12127831
Drug: Appropriate care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Appropriate care with hylan G‐F 20 (AC+H)
Trial: 12127831
Drug: Appropriate care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Appropriate care without hylan G‐F 20 (AC)
Trial: 7988780
Drug: Glipizide treatment
RxNorm normalized name: Glipizide
DrugBank: Glipizide (DB01067)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glipizide treatment
Trial: 2738213
Drug: Social problem-solving
RxNorm normalized name: Solv X
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Social problem-solving therapy
Trial: 791320
Drug: Phenobarbitone (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenobarbitone (50 mg) 8-hourly for 3 weeks
Trial: 791320
Drug: Orphenadrine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orphenadrine (100 mg) 8-hourly for 3 weeks
Trial: 791320
Drug: Chlorpromazine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorpromazine (100 mg) 8-hourly
Trial: 20410233
Drug: Pasireotide 200-600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pasireotide 200-600 microg s.c. twice daily for 28 days
Trial: 20410233
Drug: Octreotide 100
RxNorm normalized name: 1 ML octreotide 100 MCG/ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Octreotide 100 microg s.c. three times daily for 28 days
Trial: 18765397
Drug: Darapladib (160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Darapladib (160 mg daily)
Trial: 12501878
Drug: Cefpodoxime 200
RxNorm normalized name: cefpodoxime 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefpodoxime 200 mg BID
Trial: 8524980
Drug: Diazepam (DZP)
DrugBank: Diazepam (DB00829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Diazepam (DZP) 5 mg
Trial: 8524980
Drug: Diazepam (DZP)
DrugBank: Diazepam (DB00829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Diazepam (DZP) 10 mg
Trial: 35214
Drug: Alcohol +
RxNorm normalized name: Benzyl alcohol + eucalyptus oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcohol + Clobazam 20 mg
Trial: 25733676
Drug: Hypnotic medication
RxNorm normalized name: Synotic
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hypnotic medication as an add-on treatment to a selective serotonin reuptake inhibitor